[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Active Implantable Devices Market Growth 2022-2028

February 2022 | 109 pages | ID: G3CF25D471DDEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Active Implantable Devices will have significant change from previous year. According to our (LP Information) latest study, the global Active Implantable Devices market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Active Implantable Devices market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Active Implantable Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Active Implantable Devices market, reaching US$ million by the year 2028. As for the Europe Active Implantable Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Active Implantable Devices players cover LivaNova PLC(U.K.), MED-EL(Austria), Medtronic(Ireland), and Abbott Laboratories(U.S.), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Active Implantable Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
  • Implantable Cardioverter Defibrillator
  • Implantable Cardiac Pacemakers
  • Ventricular Assist Devices
  • Implantable Heart Monitors/Insertable Loop Recorders
  • Neurostimulators
  • Implantable Hearing Devices
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
  • Hospital
  • Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
  • LivaNova PLC(U.K.)
  • MED-EL(Austria)
  • Medtronic(Ireland)
  • Abbott Laboratories(U.S.)
  • BIOTRONIK(Germany)
  • Boston Scientific Corporation(U.S.)
  • Cochlear Limited(Australia)
  • Nurotron Biotechnology(China)
  • Sonova Holding Switzerland)
  • William Demant Holding(Denmark)
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Active Implantable Devices Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Active Implantable Devices by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Active Implantable Devices by Country/Region, 2017, 2022 & 2028
2.2 Active Implantable Devices Segment by Type
  2.2.1 Implantable Cardioverter Defibrillator
  2.2.2 Implantable Cardiac Pacemakers
  2.2.3 Ventricular Assist Devices
  2.2.4 Implantable Heart Monitors/Insertable Loop Recorders
  2.2.5 Neurostimulators
  2.2.6 Implantable Hearing Devices
2.3 Active Implantable Devices Sales by Type
  2.3.1 Global Active Implantable Devices Sales Market Share by Type (2017-2022)
  2.3.2 Global Active Implantable Devices Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Active Implantable Devices Sale Price by Type (2017-2022)
2.4 Active Implantable Devices Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
2.5 Active Implantable Devices Sales by Application
  2.5.1 Global Active Implantable Devices Sale Market Share by Application (2017-2022)
  2.5.2 Global Active Implantable Devices Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Active Implantable Devices Sale Price by Application (2017-2022)

3 GLOBAL ACTIVE IMPLANTABLE DEVICES BY COMPANY

3.1 Global Active Implantable Devices Breakdown Data by Company
  3.1.1 Global Active Implantable Devices Annual Sales by Company (2020-2022)
  3.1.2 Global Active Implantable Devices Sales Market Share by Company (2020-2022)
3.2 Global Active Implantable Devices Annual Revenue by Company (2020-2022)
  3.2.1 Global Active Implantable Devices Revenue by Company (2020-2022)
  3.2.2 Global Active Implantable Devices Revenue Market Share by Company (2020-2022)
3.3 Global Active Implantable Devices Sale Price by Company
3.4 Key Manufacturers Active Implantable Devices Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Active Implantable Devices Product Location Distribution
  3.4.2 Players Active Implantable Devices Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR ACTIVE IMPLANTABLE DEVICES BY GEOGRAPHIC REGION

4.1 World Historic Active Implantable Devices Market Size by Geographic Region (2017-2022)
  4.1.1 Global Active Implantable Devices Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Active Implantable Devices Annual Revenue by Geographic Region
4.2 World Historic Active Implantable Devices Market Size by Country/Region (2017-2022)
  4.2.1 Global Active Implantable Devices Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Active Implantable Devices Annual Revenue by Country/Region
4.3 Americas Active Implantable Devices Sales Growth
4.4 APAC Active Implantable Devices Sales Growth
4.5 Europe Active Implantable Devices Sales Growth
4.6 Middle East & Africa Active Implantable Devices Sales Growth

5 AMERICAS

5.1 Americas Active Implantable Devices Sales by Country
  5.1.1 Americas Active Implantable Devices Sales by Country (2017-2022)
  5.1.2 Americas Active Implantable Devices Revenue by Country (2017-2022)
5.2 Americas Active Implantable Devices Sales by Type
5.3 Americas Active Implantable Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Active Implantable Devices Sales by Region
  6.1.1 APAC Active Implantable Devices Sales by Region (2017-2022)
  6.1.2 APAC Active Implantable Devices Revenue by Region (2017-2022)
6.2 APAC Active Implantable Devices Sales by Type
6.3 APAC Active Implantable Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Active Implantable Devices by Country
  7.1.1 Europe Active Implantable Devices Sales by Country (2017-2022)
  7.1.2 Europe Active Implantable Devices Revenue by Country (2017-2022)
7.2 Europe Active Implantable Devices Sales by Type
7.3 Europe Active Implantable Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Active Implantable Devices by Country
  8.1.1 Middle East & Africa Active Implantable Devices Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Active Implantable Devices Revenue by Country (2017-2022)
8.2 Middle East & Africa Active Implantable Devices Sales by Type
8.3 Middle East & Africa Active Implantable Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Active Implantable Devices
10.3 Manufacturing Process Analysis of Active Implantable Devices
10.4 Industry Chain Structure of Active Implantable Devices

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Active Implantable Devices Distributors
11.3 Active Implantable Devices Customer

12 WORLD FORECAST REVIEW FOR ACTIVE IMPLANTABLE DEVICES BY GEOGRAPHIC REGION

12.1 Global Active Implantable Devices Market Size Forecast by Region
  12.1.1 Global Active Implantable Devices Forecast by Region (2023-2028)
  12.1.2 Global Active Implantable Devices Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Active Implantable Devices Forecast by Type
12.7 Global Active Implantable Devices Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 LivaNova PLC(U.K.)
  13.1.1 LivaNova PLC(U.K.) Company Information
  13.1.2 LivaNova PLC(U.K.) Active Implantable Devices Product Offered
  13.1.3 LivaNova PLC(U.K.) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 LivaNova PLC(U.K.) Main Business Overview
  13.1.5 LivaNova PLC(U.K.) Latest Developments
13.2 MED-EL(Austria)
  13.2.1 MED-EL(Austria) Company Information
  13.2.2 MED-EL(Austria) Active Implantable Devices Product Offered
  13.2.3 MED-EL(Austria) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 MED-EL(Austria) Main Business Overview
  13.2.5 MED-EL(Austria) Latest Developments
13.3 Medtronic(Ireland)
  13.3.1 Medtronic(Ireland) Company Information
  13.3.2 Medtronic(Ireland) Active Implantable Devices Product Offered
  13.3.3 Medtronic(Ireland) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Medtronic(Ireland) Main Business Overview
  13.3.5 Medtronic(Ireland) Latest Developments
13.4 Abbott Laboratories(U.S.)
  13.4.1 Abbott Laboratories(U.S.) Company Information
  13.4.2 Abbott Laboratories(U.S.) Active Implantable Devices Product Offered
  13.4.3 Abbott Laboratories(U.S.) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Abbott Laboratories(U.S.) Main Business Overview
  13.4.5 Abbott Laboratories(U.S.) Latest Developments
13.5 BIOTRONIK(Germany)
  13.5.1 BIOTRONIK(Germany) Company Information
  13.5.2 BIOTRONIK(Germany) Active Implantable Devices Product Offered
  13.5.3 BIOTRONIK(Germany) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 BIOTRONIK(Germany) Main Business Overview
  13.5.5 BIOTRONIK(Germany) Latest Developments
13.6 Boston Scientific Corporation(U.S.)
  13.6.1 Boston Scientific Corporation(U.S.) Company Information
  13.6.2 Boston Scientific Corporation(U.S.) Active Implantable Devices Product Offered
  13.6.3 Boston Scientific Corporation(U.S.) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Boston Scientific Corporation(U.S.) Main Business Overview
  13.6.5 Boston Scientific Corporation(U.S.) Latest Developments
13.7 Cochlear Limited(Australia)
  13.7.1 Cochlear Limited(Australia) Company Information
  13.7.2 Cochlear Limited(Australia) Active Implantable Devices Product Offered
  13.7.3 Cochlear Limited(Australia) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Cochlear Limited(Australia) Main Business Overview
  13.7.5 Cochlear Limited(Australia) Latest Developments
13.8 Nurotron Biotechnology(China)
  13.8.1 Nurotron Biotechnology(China) Company Information
  13.8.2 Nurotron Biotechnology(China) Active Implantable Devices Product Offered
  13.8.3 Nurotron Biotechnology(China) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Nurotron Biotechnology(China) Main Business Overview
  13.8.5 Nurotron Biotechnology(China) Latest Developments
13.9 Sonova Holding Switzerland)
  13.9.1 Sonova Holding Switzerland) Company Information
  13.9.2 Sonova Holding Switzerland) Active Implantable Devices Product Offered
  13.9.3 Sonova Holding Switzerland) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Sonova Holding Switzerland) Main Business Overview
  13.9.5 Sonova Holding Switzerland) Latest Developments
13.10 William Demant Holding(Denmark)
  13.10.1 William Demant Holding(Denmark) Company Information
  13.10.2 William Demant Holding(Denmark) Active Implantable Devices Product Offered
  13.10.3 William Demant Holding(Denmark) Active Implantable Devices Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 William Demant Holding(Denmark) Main Business Overview
  13.10.5 William Demant Holding(Denmark) Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Active Implantable Devices Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Active Implantable Devices Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Implantable Cardioverter Defibrillator
Table 4. Major Players of Implantable Cardiac Pacemakers
Table 5. Major Players of Ventricular Assist Devices
Table 6. Major Players of Implantable Heart Monitors/Insertable Loop Recorders
Table 7. Major Players of Neurostimulators
Table 8. Major Players of Implantable Hearing Devices
Table 9. Global Active Implantable Devices Sales by Type (2017-2022) & (Units)
Table 10. Global Active Implantable Devices Sales Market Share by Type (2017-2022)
Table 11. Global Active Implantable Devices Revenue by Type (2017-2022) & ($ million)
Table 12. Global Active Implantable Devices Revenue Market Share by Type (2017-2022)
Table 13. Global Active Implantable Devices Sale Price by Type (2017-2022) & (USD/Unit)
Table 14. Global Active Implantable Devices Sales by Application (2017-2022) & (Units)
Table 15. Global Active Implantable Devices Sales Market Share by Application (2017-2022)
Table 16. Global Active Implantable Devices Revenue by Application (2017-2022)
Table 17. Global Active Implantable Devices Revenue Market Share by Application (2017-2022)
Table 18. Global Active Implantable Devices Sale Price by Application (2017-2022) & (USD/Unit)
Table 19. Global Active Implantable Devices Sales by Company (2020-2022) & (Units)
Table 20. Global Active Implantable Devices Sales Market Share by Company (2020-2022)
Table 21. Global Active Implantable Devices Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Active Implantable Devices Revenue Market Share by Company (2020-2022)
Table 23. Global Active Implantable Devices Sale Price by Company (2020-2022) & (USD/Unit)
Table 24. Key Manufacturers Active Implantable Devices Producing Area Distribution and Sales Area
Table 25. Players Active Implantable Devices Products Offered
Table 26. Active Implantable Devices Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Active Implantable Devices Sales by Geographic Region (2017-2022) & (Units)
Table 30. Global Active Implantable Devices Sales Market Share Geographic Region (2017-2022)
Table 31. Global Active Implantable Devices Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Active Implantable Devices Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Active Implantable Devices Sales by Country/Region (2017-2022) & (Units)
Table 34. Global Active Implantable Devices Sales Market Share by Country/Region (2017-2022)
Table 35. Global Active Implantable Devices Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Active Implantable Devices Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Active Implantable Devices Sales by Country (2017-2022) & (Units)
Table 38. Americas Active Implantable Devices Sales Market Share by Country (2017-2022)
Table 39. Americas Active Implantable Devices Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Active Implantable Devices Revenue Market Share by Country (2017-2022)
Table 41. Americas Active Implantable Devices Sales by Type (2017-2022) & (Units)
Table 42. Americas Active Implantable Devices Sales Market Share by Type (2017-2022)
Table 43. Americas Active Implantable Devices Sales by Application (2017-2022) & (Units)
Table 44. Americas Active Implantable Devices Sales Market Share by Application (2017-2022)
Table 45. APAC Active Implantable Devices Sales by Region (2017-2022) & (Units)
Table 46. APAC Active Implantable Devices Sales Market Share by Region (2017-2022)
Table 47. APAC Active Implantable Devices Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Active Implantable Devices Revenue Market Share by Region (2017-2022)
Table 49. APAC Active Implantable Devices Sales by Type (2017-2022) & (Units)
Table 50. APAC Active Implantable Devices Sales Market Share by Type (2017-2022)
Table 51. APAC Active Implantable Devices Sales by Application (2017-2022) & (Units)
Table 52. APAC Active Implantable Devices Sales Market Share by Application (2017-2022)
Table 53. Europe Active Implantable Devices Sales by Country (2017-2022) & (Units)
Table 54. Europe Active Implantable Devices Sales Market Share by Country (2017-2022)
Table 55. Europe Active Implantable Devices Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Active Implantable Devices Revenue Market Share by Country (2017-2022)
Table 57. Europe Active Implantable Devices Sales by Type (2017-2022) & (Units)
Table 58. Europe Active Implantable Devices Sales Market Share by Type (2017-2022)
Table 59. Europe Active Implantable Devices Sales by Application (2017-2022) & (Units)
Table 60. Europe Active Implantable Devices Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Active Implantable Devices Sales by Country (2017-2022) & (Units)
Table 62. Middle East & Africa Active Implantable Devices Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Active Implantable Devices Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Active Implantable Devices Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Active Implantable Devices Sales by Type (2017-2022) & (Units)
Table 66. Middle East & Africa Active Implantable Devices Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Active Implantable Devices Sales by Application (2017-2022) & (Units)
Table 68. Middle East & Africa Active Implantable Devices Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Active Implantable Devices
Table 70. Key Market Challenges & Risks of Active Implantable Devices
Table 71. Key Industry Trends of Active Implantable Devices
Table 72. Active Implantable Devices Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Active Implantable Devices Distributors List
Table 75. Active Implantable Devices Customer List
Table 76. Global Active Implantable Devices Sales Forecast by Region (2023-2028) & (Units)
Table 77. Global Active Implantable Devices Sales Market Forecast by Region
Table 78. Global Active Implantable Devices Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Active Implantable Devices Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Active Implantable Devices Sales Forecast by Country (2023-2028) & (Units)
Table 81. Americas Active Implantable Devices Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Active Implantable Devices Sales Forecast by Region (2023-2028) & (Units)
Table 83. APAC Active Implantable Devices Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Active Implantable Devices Sales Forecast by Country (2023-2028) & (Units)
Table 85. Europe Active Implantable Devices Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Active Implantable Devices Sales Forecast by Country (2023-2028) & (Units)
Table 87. Middle East & Africa Active Implantable Devices Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Active Implantable Devices Sales Forecast by Type (2023-2028) & (Units)
Table 89. Global Active Implantable Devices Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Active Implantable Devices Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Active Implantable Devices Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Active Implantable Devices Sales Forecast by Application (2023-2028) & (Units)
Table 93. Global Active Implantable Devices Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Active Implantable Devices Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Active Implantable Devices Revenue Market Share Forecast by Application (2023-2028)
Table 96. LivaNova PLC(U.K.) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 97. LivaNova PLC(U.K.) Active Implantable Devices Product Offered
Table 98. LivaNova PLC(U.K.) Active Implantable Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 99. LivaNova PLC(U.K.) Main Business
Table 100. LivaNova PLC(U.K.) Latest Developments
Table 101. MED-EL(Austria) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 102. MED-EL(Austria) Active Implantable Devices Product Offered
Table 103. MED-EL(Austria) Active Implantable Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 104. MED-EL(Austria) Main Business
Table 105. MED-EL(Austria) Latest Developments
Table 106. Medtronic(Ireland) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 107. Medtronic(Ireland) Active Implantable Devices Product Offered
Table 108. Medtronic(Ireland) Active Implantable Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 109. Medtronic(Ireland) Main Business
Table 110. Medtronic(Ireland) Latest Developments
Table 111. Abbott Laboratories(U.S.) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 112. Abbott Laboratories(U.S.) Active Implantable Devices Product Offered
Table 113. Abbott Laboratories(U.S.) Active Implantable Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 114. Abbott Laboratories(U.S.) Main Business
Table 115. Abbott Laboratories(U.S.) Latest Developments
Table 116. BIOTRONIK(Germany) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 117. BIOTRONIK(Germany) Active Implantable Devices Product Offered
Table 118. BIOTRONIK(Germany) Active Implantable Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 119. BIOTRONIK(Germany) Main Business
Table 120. BIOTRONIK(Germany) Latest Developments
Table 121. Boston Scientific Corporation(U.S.) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 122. Boston Scientific Corporation(U.S.) Active Implantable Devices Product Offered
Table 123. Boston Scientific Corporation(U.S.) Active Implantable Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 124. Boston Scientific Corporation(U.S.) Main Business
Table 125. Boston Scientific Corporation(U.S.) Latest Developments
Table 126. Cochlear Limited(Australia) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 127. Cochlear Limited(Australia) Active Implantable Devices Product Offered
Table 128. Cochlear Limited(Australia) Active Implantable Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 129. Cochlear Limited(Australia) Main Business
Table 130. Cochlear Limited(Australia) Latest Developments
Table 131. Nurotron Biotechnology(China) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 132. Nurotron Biotechnology(China) Active Implantable Devices Product Offered
Table 133. Nurotron Biotechnology(China) Active Implantable Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 134. Nurotron Biotechnology(China) Main Business
Table 135. Nurotron Biotechnology(China) Latest Developments
Table 136. Sonova Holding Switzerland) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 137. Sonova Holding Switzerland) Active Implantable Devices Product Offered
Table 138. Sonova Holding Switzerland) Active Implantable Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 139. Sonova Holding Switzerland) Main Business
Table 140. Sonova Holding Switzerland) Latest Developments
Table 141. William Demant Holding(Denmark) Basic Information, Active Implantable Devices Manufacturing Base, Sales Area and Its Competitors
Table 142. William Demant Holding(Denmark) Active Implantable Devices Product Offered
Table 143. William Demant Holding(Denmark) Active Implantable Devices Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 144. William Demant Holding(Denmark) Main Business
Table 145. William Demant Holding(Denmark) Latest Developments

LIST OF FIGURES

Figure 1. Picture of Active Implantable Devices
Figure 2. Active Implantable Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Active Implantable Devices Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Active Implantable Devices Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Active Implantable Devices Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Implantable Cardioverter Defibrillator
Figure 10. Product Picture of Implantable Cardiac Pacemakers
Figure 11. Product Picture of Ventricular Assist Devices
Figure 12. Product Picture of Implantable Heart Monitors/Insertable Loop Recorders
Figure 13. Product Picture of Neurostimulators
Figure 14. Product Picture of Implantable Hearing Devices
Figure 15. Global Active Implantable Devices Sales Market Share by Type in 2021
Figure 16. Global Active Implantable Devices Revenue Market Share by Type (2017-2022)
Figure 17. Active Implantable Devices Consumed in Hospital
Figure 18. Global Active Implantable Devices Market: Hospital (2017-2022) & (Units)
Figure 19. Active Implantable Devices Consumed in Clinic
Figure 20. Global Active Implantable Devices Market: Clinic (2017-2022) & (Units)
Figure 21. Global Active Implantable Devices Sales Market Share by Application (2017-2022)
Figure 22. Global Active Implantable Devices Revenue Market Share by Application in 2021
Figure 23. Active Implantable Devices Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Active Implantable Devices Revenue Market Share by Company in 2021
Figure 25. Global Active Implantable Devices Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Active Implantable Devices Revenue Market Share by Geographic Region in 2021
Figure 27. Global Active Implantable Devices Sales Market Share by Region (2017-2022)
Figure 28. Global Active Implantable Devices Revenue Market Share by Country/Region in 2021
Figure 29. Americas Active Implantable Devices Sales 2017-2022 (Units)
Figure 30. Americas Active Implantable Devices Revenue 2017-2022 ($ Millions)
Figure 31. APAC Active Implantable Devices Sales 2017-2022 (Units)
Figure 32. APAC Active Implantable Devices Revenue 2017-2022 ($ Millions)
Figure 33. Europe Active Implantable Devices Sales 2017-2022 (Units)
Figure 34. Europe Active Implantable Devices Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Active Implantable Devices Sales 2017-2022 (Units)
Figure 36. Middle East & Africa Active Implantable Devices Revenue 2017-2022 ($ Millions)
Figure 37. Americas Active Implantable Devices Sales Market Share by Country in 2021
Figure 38. Americas Active Implantable Devices Revenue Market Share by Country in 2021
Figure 39. United States Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Active Implantable Devices Sales Market Share by Region in 2021
Figure 44. APAC Active Implantable Devices Revenue Market Share by Regions in 2021
Figure 45. China Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Active Implantable Devices Sales Market Share by Country in 2021
Figure 52. Europe Active Implantable Devices Revenue Market Share by Country in 2021
Figure 53. Germany Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Active Implantable Devices Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Active Implantable Devices Revenue Market Share by Country in 2021
Figure 60. Egypt Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Active Implantable Devices Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Active Implantable Devices in 2021
Figure 66. Manufacturing Process Analysis of Active Implantable Devices
Figure 67. Industry Chain Structure of Active Implantable Devices
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles


More Publications